abstract |
COX-2 expression inhibitors which contain as the active ingredient dihydroxyacetophenone derivatives represented by the following general formula (1). These COX-2 expression inhibitors are useful in preventing cancer associated with the overexpression of COX-2 such as colon cancer. |